Oura agrees to buy AI primary care start-up Counsel Health for $625m in cash

Oura, the smart ring maker, said on 10 November that it will pay $625 million in cash for Counsel Health, a start-up that runs an AI chatbot for health questions backed by physicians over telehealth¹². Oura expects the deal to close before the end of the year, subject to purchase price adjustments and customary closing conditions².

What Oura is buying

Counsel's service starts with an AI conversation. Its agents take a medical history, retrieve guidelines, review records and screen for emergencies, then offer guidance drawing on that information, earlier conversations and biometric data². Users can bring a physician into the chat, who can diagnose, prescribe or refer². Counsel had previously disclosed $36 million in funding, so the price is large relative to the capital it had raised publicly¹.

Oura plans to run Counsel's platform inside the Oura app and connect it to the data its rings collect². Counsel founder and chief executive Muthu Alagappan said the combination gives physicians context, biometric data and member engagement². The acquisition adds to a run of health features and medtech partnerships at Oura, including with Resmed and Dexcom².

What it means for the market

The deal is a wearable company buying a care delivery business outright rather than partnering for one. It reflects a growing push to tie consumer devices into clinical care, and the view that AI chatbots will become a standard entry point to it¹. For virtual primary care and AI triage vendors, a consumer hardware company with an installed user base has become a credible acquirer, which matters for exit options in this segment¹².

The timing also matters for investors. Oura sought to raise up to $2.2 billion in an initial public offering in September and then delayed it later that month, citing market uncertainty². Spending $625 million in cash on an acquisition shortly afterwards indicates the company is building its clinical offer while it stays private, and the IPO story it eventually tells will now include care delivery as well as devices¹².

For health systems and payers, a direct-to-consumer route into primary care that combines continuous ring data with on-demand physicians is a competitor for low-acuity demand, since physicians in the chat can diagnose, prescribe or refer². The sources give no detail on reimbursement, insurance coverage or the markets where the service will run¹².

Caveats

The sources give no revenue, user or clinical outcome figures for Counsel, and no information on how many clinicians it employs¹². The purchase price is subject to adjustment, and completion still depends on customary closing conditions, with Oura aiming to finish before the end of the year².